Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Joo-Yong Hahn Added: 8 months ago
ACC 25 - SMART-CHOICE 3 Trial finds clopidogrel monotherapy to be the optimal anti-thrombotic strategy in high risk patients with contemporary drug-eluting stents.Dr Joo-Yong Hahn (Samsung Medical Center, Seoul, KR) joins us onsite at ACC Conference 2025 to discuss the findings from the SMART-CHOICE 3 study (NCT04418479). The study aims to evaluate the efficacy and safety of clopidogrel… View more
Job title: Associate Professor of Medicine, FHML; Medical Director, Anticoagulation Clinic, Maastricht University Medical Center
Dr Arina ten Cate-Hoek is a medical doctor and clinical epidemiologist. She currently holds a clinical position at the Heart+Vascular Center of Maastricht UMC+ and her speciality is in the prevention and treatment of venous thrombotic disease, especially post-thrombotic syndrome. She is the medical director of the Anticoagulation Clinic as well as the medical coordinator of the Thrombosis… View more
Job title: Chairman of the lipid clinic
Prof Erik Stroes is Chairman of the lipid clinic at Amsterdam University Medical Center (UMC) in the Netherlands. Prof Stroes is a vascular internist with a longstanding track of research in the field of lipidology, inflammation and atherosclerosis. His current research foci encompass the use of CT-angiography as a guide to tailored treatment regimens, pathophysiology of Lp(a) in atherogenesis… View more
Author(s): Ling Tao Added: 1 year ago
EuroPCR 2024 — Investigator, Dr Ling Tao joins us to discuss the findings from the CAGEFREE II trial.Compared to drug-eluting stents, drug-coated balloons are associated with faster vessel healing and reduced thrombotic burden, therefore patients treated with DCBs require a less intensive antiplatelet therapy. CAGEFREE II investigated the effectiveness and safety of a tailored one-month DAPT… View more
Job title: Senior Consultant Specialist
Personal History Dr Antonia Sambola is an expert in acute coronary syndromes and cardiovascular thrombotic disorders. She is a senior consultant specialist in acute cardiac care at Hospital Universitari de la Vall d'Hebron in Barcelona, Spain.1, 2 Academic History Dr Sambola was awarded a master's degree in statistical and epidemiology sciences in 1987 from Universitat Autònoma de… View more
Author(s): Rasha Al-Lamee , Christopher Rajkumar , Nazli Okumus Added: 2 years ago
AHA 2023 — Investigators of ORBITA-2 trial, Dr Rasha Al-Lamee and Dr Christopher Rajkumar (Imperial College London, UK) talked with CardioNerds Ambassador, Dr Nazli Okumus about the randomised, placebo-controlled trial (NCT03742050) that compared the effects of coronary angioplasty versus placebo procedure on symptoms of stable angina without background anti-anginal therapy at 12 weeks.The ORBITA… View more
Author(s): Mandeep Mehra , Christian Inchaustegui Added: 2 years ago
In 2023, we are excited to partner with @CardioNerds, a dynamic team dedicated to democratizing cardiovascular education. Experience a fresh perspective on the new data through an interview series featuring principal investigators and ambassadors from the CardioNerds family.These interviews are supported by an educational grant from Novo Nordisk Inc. This content is not intended for UK HCPs. View more
Research Area(s) / Expertise: Job title: Professor of Angiology / Director University Clinic of Angiology
Prof Nils Kucher is aProfessor of Angiology and Director University Clinic of Angiology at University Hospital Zürich, Zürich, CH. He specialises in minimally invasive endovascular treatment of acute pulmonary embolism, acute deep vein thrombosis, and the post-thrombotic syndrome. From 2016-2017 he was Chief Physician of Angiology at University Hospital Bern, where earlier he fulfilled the… View more